Substance
INFLIXIMAB
Global reference: every product and company linked to this substance.
- cas: 170277-31-3
- ncit: C1789
- rxnorm: 191831
- unii: B72HH48FLU
infliximab [INN] · INFLIXIMAB [JAN] · INFLIXIMAB [USAN] · Infliximab [WHO-DD] · TA-650
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | REMICADE | Q2 2026 | $338.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- REMICADE · JOHNSON & JOHNSON COMMON STOCK